F. Hoffmann-La Roche AG, commonly known as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, boasting a robust portfolio of core products, including groundbreaking biologics and diagnostic tools. The company’s unique approach to integrating pharmaceuticals and diagnostics sets it apart in the market, enabling tailored treatment options for patients. Roche's notable achievements include being consistently ranked among the top pharmaceutical companies worldwide, reflecting its dedication to advancing healthcare and improving patient outcomes.
How does F. Hoffmann-La Roche AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
F. Hoffmann-La Roche AG's score of 90 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, F. Hoffmann-La Roche AG reported total carbon emissions of approximately 5,474,000,000 kg CO2e, with emissions distributed across all three scopes: 245,832,000 kg CO2e (Scope 1), 69,198,000 kg CO2e (Scope 2), and 5,478,525,000 kg CO2e (Scope 3). The Scope 3 emissions are particularly significant, accounting for about 99% of the total emissions, highlighting the importance of addressing upstream and downstream activities in their climate strategy. In 2023, the company recorded total emissions of about 5,978,508,000 kg CO2e, with Scope 1 emissions at 240,266,000 kg CO2e and Scope 2 emissions at 98,480,000 kg CO2e. This indicates a slight reduction in total emissions from the previous year, reflecting ongoing efforts to improve sustainability. F. Hoffmann-La Roche AG has set a mid-term goal to reduce energy consumption from Scope 1 and Scope 2 sources per employee by 15% by 2025, starting from a baseline established in 2015. This commitment demonstrates the company's focus on enhancing energy efficiency within its facilities. The emissions data is cascaded from Roche Holding AG, the parent company, which also influences the climate initiatives and targets set by F. Hoffmann-La Roche AG. The company actively participates in various climate initiatives, although specific SBTi targets were not disclosed. Overall, F. Hoffmann-La Roche AG's emissions profile and reduction commitments reflect a comprehensive approach to tackling climate change, with a strong emphasis on reducing energy consumption and addressing the substantial Scope 3 emissions that dominate their carbon footprint.
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 419,306,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 443,583,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 160,632,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
F. Hoffmann-La Roche AG's Scope 3 emissions, which decreased by 8% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
F. Hoffmann-La Roche AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.